ZA892517B - Propanamine derivatives - Google Patents

Propanamine derivatives

Info

Publication number
ZA892517B
ZA892517B ZA892517A ZA892517A ZA892517B ZA 892517 B ZA892517 B ZA 892517B ZA 892517 A ZA892517 A ZA 892517A ZA 892517 A ZA892517 A ZA 892517A ZA 892517 B ZA892517 B ZA 892517B
Authority
ZA
South Africa
Prior art keywords
propanamine derivatives
propanamine
derivatives
substitutedphenoxy
propanamines
Prior art date
Application number
ZA892517A
Other languages
English (en)
Inventor
David Waybe Robertson
Waybe Robertson David
David Taiwai Wong
Taiwai Wong David
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA892517B publication Critical patent/ZA892517B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Addiction (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA892517A 1988-04-08 1989-04-05 Propanamine derivatives ZA892517B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17936888A 1988-04-08 1988-04-08

Publications (1)

Publication Number Publication Date
ZA892517B true ZA892517B (en) 1990-12-28

Family

ID=22656301

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA892517A ZA892517B (en) 1988-04-08 1989-04-05 Propanamine derivatives

Country Status (19)

Country Link
EP (1) EP0336753B1 (xx)
JP (1) JPH0285236A (xx)
KR (1) KR890015995A (xx)
CN (1) CN1036562A (xx)
AT (1) ATE78029T1 (xx)
AU (1) AU611794B2 (xx)
CA (1) CA1337128C (xx)
DE (1) DE68901994T2 (xx)
DK (1) DK165489A (xx)
ES (1) ES2033525T3 (xx)
GR (1) GR3005662T3 (xx)
HU (1) HU205344B (xx)
IE (1) IE891122L (xx)
IL (1) IL89854A (xx)
NZ (1) NZ228636A (xx)
PH (1) PH27144A (xx)
PT (1) PT90212B (xx)
SU (1) SU1750421A3 (xx)
ZA (1) ZA892517B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
CA2042346A1 (en) * 1990-05-17 1991-11-18 Michael Alexander Staszak Chiral synthesis of 1-aryl-3-aminopropan-1-ols
DK0537915T3 (da) * 1991-09-27 1995-11-27 Lilly Co Eli N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylaminer som inhibitorer for epinephrin
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
IL110857A0 (en) * 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
US5936124A (en) * 1998-06-22 1999-08-10 Sepacor Inc. Fluoxetine process from benzoylpropionic acid
US6025517A (en) * 1998-08-03 2000-02-15 Sepracor Inc. Fluoxetine process from benzoylacetonitrile
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
DE2732750A1 (de) * 1977-07-20 1979-02-08 Merck Patent Gmbh Basische thioaether und verfahren zu ihrer herstellung
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
US4147805A (en) * 1978-07-28 1979-04-03 Mead Johnson & Company Alkylthiophenoxyalkylamines and the pharmaceutical use thereof
GB2060622B (en) * 1979-09-14 1983-05-25 Wyeth John & Brother Ltd 3-aryl-3-aryloxyalkylamines
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines

Also Published As

Publication number Publication date
AU611794B2 (en) 1991-06-20
PH27144A (en) 1993-04-02
IE891122L (en) 1989-10-08
NZ228636A (en) 1990-12-21
DK165489D0 (da) 1989-04-06
IL89854A (en) 1994-02-27
AU3252889A (en) 1989-10-12
EP0336753B1 (en) 1992-07-08
ES2033525T3 (es) 1993-03-16
DE68901994T2 (de) 1993-02-25
CA1337128C (en) 1995-09-26
HU205344B (en) 1992-04-28
PT90212A (pt) 1989-11-10
DK165489A (da) 1989-10-09
JPH0285236A (ja) 1990-03-26
SU1750421A3 (ru) 1992-07-23
KR890015995A (ko) 1989-11-27
EP0336753A1 (en) 1989-10-11
HUT54976A (en) 1991-04-29
PT90212B (pt) 1994-06-30
ATE78029T1 (de) 1992-07-15
DE68901994D1 (de) 1992-08-13
GR3005662T3 (xx) 1993-06-07
CN1036562A (zh) 1989-10-25

Similar Documents

Publication Publication Date Title
FI895720A0 (fi) Givare- och belysningssystem foer en straeckkodlaesare av stort skaerpedjup.
AP9400666A0 (en) Benzofuran derivatives.
NL193682B (nl) Beklede cefuroximaxetilsamenstelling.
EP0338295A3 (en) Inclinable rotary platform for physical training, particularly of pre-ski type
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
DE68924246D1 (de) Tonerzusammensetzung.
IL90292A0 (en) Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
ZA892517B (en) Propanamine derivatives
DE3879364D1 (de) Rotationstransformator.
DE69003075D1 (de) Stabilisierungszusammensetzungen.
DE3854179D1 (de) Vulkanisierbare Fluorkautschukzusammensetzung.
PH30818A (en) Novel substituted thienopyrans as antihpertensive agents.
EP0490901A4 (en) NEW SPIROFUR DERIVATIVES.
DE58903514D1 (de) Derivate der 2,3-difluorbenzoesaeure.
ES503562A0 (es) Procedimiento de preparacion de 3-(1,2,4-hidroxitriazinil) tiometil cefalosporinas
IE902286L (en) Use of isoxazolin-3-one derivatives as antidepressants
FI906162A (fi) Foerfarande foer framstaellning av 3-(n-metyl-n-alkyl)-amino-2-metoximetylenpropan-1-olderivat.
DE69022202D1 (de) Abriebfeste Kautschukmischungen.
GR910300135T1 (en) Novel compounds of the diterpene type
MX9203634A (es) Derivados de pirocatecol 3,5-disubstituidos.
FI890051A0 (fi) Bankgirolaoda foersedd med styrskivor som hindrar tillbakadragning av brev.
IE892298L (en) Substituted 3-(8-ó-ergolinyl)-1,1-diethyl-ureas
FI893757A0 (fi) Foerfarande foer framstaellning av pentaerytril-tetrakis-/3-(3,5-ditert.butyl-4-hydroxifenyl) propionat.
DE68916171D1 (de) Keimtötende Zusammensetzung.
NO893996D0 (no) Reguleringsmekanisme.